Trials / Completed
CompletedNCT03763773
Prediction of Outcomes With a Miniaturized Transesophageal Echocardiography Probe in Patients With Acute Respiratory Distress Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Superior Vena cava Respiratory Collapse Index (cVCS) is a haemodynamic parameter measured exclusively by transoesophageal ultrasound (TEE), which is used to assess cardiac precharge-dependence status. This may be an important prognostic factor in ARDS because it is a sign of hypervolemia and right heart failure.
Conditions
Timeline
- Start date
- 2019-04-21
- Primary completion
- 2021-04-20
- Completion
- 2021-04-20
- First posted
- 2018-12-04
- Last updated
- 2022-04-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03763773. Inclusion in this directory is not an endorsement.